Access to anti-retroviral drugs, female in Panama

Panama: Access to anti-retroviral drugs, female was 55.0% in 2024. ▲ Rising

Latest (2024)
55.0%
Change on year
unchanged
World rank
111th
of 141 countries
All-time high
55.0%
in 2017
All-time low
6.0%
in 2000
Years of data
25
2000–2024

Access to anti-retroviral drugs, female in Panama, 2000–2024

1020304050602000201220242000: 6 %2001: 10 %2002: 12 %2003: 14 %2004: 16 %2005: 18 %2006: 20 %2007: 21 %2008: 23 %2009: 29 %2010: 28 %2011: 34 %2012: 27 %2013: 40 %2014: 39 %2015: 44 %2016: 51 %2017: 55 %2018: 45 %2019: 45 %2020: 43 %2021: 43 %2022: 54 %2023: 55 %2024: 55 %

Source: UNAIDS estimates. Measured in %.

Analysis

The most recent figure for access to anti-retroviral drugs, female in Panama is 55.0%, measured in 2024. That is the highest value across all 25 years on record.

That represents a change of up 41.0% over ten years.

Over the whole period, access to anti-retroviral drugs, female in Panama peaked at 55.0% in 2017 and was at its lowest, 6.0%, in 2000.

Panama ranks 111th of 141 countries on this measure, in the bottom quarter.

The long-run direction has been consistently rising across the 25 years of available data.

Access to anti-retroviral drugs, female in Panama, year by year

Annual values for Access to anti-retroviral drugs, female (%) in Panama, 2000 to 2024.
Year % Change
2000 6.0%
2001 10.0% +66.7%
2002 12.0% +20.0%
2003 14.0% +16.7%
2004 16.0% +14.3%
2005 18.0% +12.5%
2006 20.0% +11.1%
2007 21.0% +5.0%
2008 23.0% +9.5%
2009 29.0% +26.1%
2010 28.0% -3.4%
2011 34.0% +21.4%
2012 27.0% -20.6%
2013 40.0% +48.1%
2014 39.0% -2.5%
2015 44.0% +12.8%
2016 51.0% +15.9%
2017 55.0% +7.8%
2018 45.0% -18.2%
2019 45.0% +0.0%
2020 43.0% -4.4%
2021 43.0% +0.0%
2022 54.0% +25.6%
2023 55.0% +1.9%
2024 55.0% +0.0%

Averages by decade

DecadeAverage LowestHighest Years
2000s 16.9% 6.0% 29.0% 10
2010s 40.8% 27.0% 55.0% 10
2020s 50.0% 43.0% 55.0% 5

Countries ranked near Panama

  1. 108 Greece 57.0% compare
  2. 108 Timor-Leste 57.0% compare
  3. 110 Lithuania 56.0% compare
  4. 111 Gambia 55.0% compare
  5. 111 Paraguay 55.0% compare
  6. 114 Latvia 54.0% compare
  7. 114 Venezuela, Bolivarian Republic of 54.0% compare

See the full ranking of 160 places →

More gender data for Panama

All data for Panama →

Frequently asked questions

What is access to anti-retroviral drugs, female in Panama?
Access to anti-retroviral drugs, female in Panama was 55.0% in 2024, according to UNAIDS estimates.
What is the highest access to anti-retroviral drugs, female recorded in Panama?
The highest recorded value was 55.0% in 2017.
What is the lowest access to anti-retroviral drugs, female recorded in Panama?
The lowest recorded value was 6.0% in 2000.
How does Panama rank for access to anti-retroviral drugs, female?
Panama ranks 111th out of 141 countries with data for 2024.
Is access to anti-retroviral drugs, female rising or falling in Panama?
Over the last ten years it is up 41.0%. The long-run trend across the full record is rising.
Where does this Panama data come from?
The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Access to anti-retroviral drugs, female in Panama. Statizoid, drawing on UNAIDS estimates. Retrieved 07 September 2026, from https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-female-percent/panama/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-female-percent/panama/">Access to anti-retroviral drugs, female in Panama</a> — Statizoid

About this data

Indicator
Access to anti-retroviral drugs, female (%)
Unit
%
Source
UNAIDS estimates
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
160 places, 3,925 data points, 2000–2024
Last refreshed

The percentage of adult females living with HIV who are receiving antiretroviral therapy.